NCT04448197

Brief Summary

Insomnia and sleep disorders are prominent health problems in modern society. High working pressure, fast pace of life, the use of electronic products and other reasons lead to the high incidence of insomnia and sleep disorders, which affect people's physical and mental health seriously, long-term insomnia will increase the risk of various health problems, and may even lead to malignant accidents. There are few effective methods to treat insomnia or sleep disorders, only part of the problem can be solved by sleeping pills and psychotherapy. However, drug therapy has side effects such as drowsiness on the next day, ataxia, anterograde amnesia and so on, and long-term application is addictive. Traditional Chinese medicine (TCM) has certain characteristics and advantages in the treatment of insomnia, but there is lack of evidence in clinical research that meets the requirements of modern evidence-based medicine, to prove the exact efficacy and safety of TCM in the treatment of insomnia. In addition, the research shows that the internal biological clock cycle of normal human body is 24-hour, insomnia may be related to biological clock gene. In this study, the outpatients with insomnia were taken as the research object. To observe the efficacy and safety of TCM in the treatment of insomnia by recording the participants' baseline demographic data, questionnaire survey, and conducting hematology examination. At the same time, to know the TCM constitution type of insomnia patients, through questionnaire survey with "Classification and Determination of TCM constitution table" that published by China Association of Chinese Medicine.And to explore the correlation between insomnia and circadian rhythm of biological clock .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2020

Completed
22 days until next milestone

Study Start

First participant enrolled

March 4, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 25, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2021

Completed
Last Updated

August 24, 2021

Status Verified

August 1, 2021

Enrollment Period

8 months

First QC Date

February 11, 2020

Last Update Submit

August 22, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline in the total score of the Pittsburgh sleep quality index (PSQI) at Month 1

    The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Possible scores range from 0(the best sleep quality) to 21(the worst possible sleep quality).The higher the score of PSQI, the worse the sleep quality. Change=(Month 1 Score-Baseline Score)

    Baseline and month 1

  • Change from Baseline in the total score of the 17-item Hamilton Depression Scale (HAMD-17) at Month 1

    The 17-item Hamilton Depression Rating Scale(HAMD-17) assesses severity ranges of depression: no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe depression (≥24). Possible scores range from 0(no depression) to 54(the worst possible depression). The higher the score of HAMD-17, the heavier the depression. Change=(Month 1 Score-Baseline Score)

    Baseline and month 1

Secondary Outcomes (6)

  • Change in of the ALT,to evaluate the safety of TCM treatment

    Baseline and month 1

  • Change in of the AST,to evaluate the safety of TCM treatment

    Baseline and month 1

  • Change in of the BUN,to evaluate the safety of TCM treatment

    Baseline and month 1

  • Change in of the Scr,to evaluate the safety of TCM treatment

    Baseline and month 1

  • Change in of the Hcy,to evaluate the safety of TCM treatment

    Baseline and month 1

  • +1 more secondary outcomes

Interventions

Dialectical treatment of traditional Chinese medicine according to different constitution

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Outpatients or inpatients of The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital) ,age 18-75 years old, male and female unlimited,in line with the Chinese adult insomnia diagnosis and treatment guidelines (2017 version) insomnia diagnosis standards, informed consent, voluntary participation in this study.

You may qualify if:

  • Outpatients or inpatients.
  • It conforms to the insomnia diagnosis standard of Chinese adult insomnia diagnosis and treatment guide (2017 Edition).
  • Informed consent, voluntary participation in the study.

You may not qualify if:

  • Sleep apnea syndrome leads to insomnia.
  • Severe depression, suicidal tendency or having committed suicide.
  • Pregnant and lactating women.
  • It has serious primary heart, liver, lung, kidney, blood or serious diseases affecting its survival, such as: tumor or AIDS, SCR \> 1.5n (n is the upper limit of normal value), ALT \> 2n (n is the upper limit of normal value), WBC \< 3.0 × 109 / L;
  • Those who cannot give full informed consent due to mental disorders.
  • According to the researcher's judgment, other situations that are not suitable for the group, such as the change of working environment and other vulnerable interviewers.
  • Patients who are participating in other clinical studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 224000, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Routine blood test

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Xiuqin Wang, doctor

    The First Affiliated Hospital with Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief physician

Study Record Dates

First Submitted

February 11, 2020

First Posted

June 25, 2020

Study Start

March 4, 2020

Primary Completion

October 16, 2020

Study Completion

January 30, 2021

Last Updated

August 24, 2021

Record last verified: 2021-08

Locations